Table 2:

Outcomes and health services use after cardiac surgery, stratified by CFS score

VariableNo. (%) of patients*Adjusted HR (95% CI)
Overall
n = 529
CFS ≥ 5
n = 51, 9.6%
CFS = 4
n ≤ 478, 90.4%
Mortality
 CVICU mortality4 (0.8)2 (3.9)2 (0.4)1.43 (0.12 to 16.72)
 Hospital mortality10 (1.9)5 (9.8)5 (1.0)3.84 (0.90 to 16.34)
 6-month mortality12 (2.3)5 (9.8)7 (1.5)6.02 (1.79 to 20.23)
 12-month mortality18 (3.4)6 (11.8)12 (2.5)4.34 (1.54 to 12.19)
 5-year mortality66 (12.5)13 (25.5)53 (11.1)2.21 (1.16 to 4.21)
Health services useMedian difference (95% CI)
 CVICU stay, d, median (IQR)1 (1–3)3 (1–5)1 (1–3)2 (2 to 3)
 Post-CVICU hospital stay, d, median (IQR)5 (4–8)9 (6–17)5 (4–7)8 (7 to 9)
 Preoperative hospital stay, d, mean ± SD1 ± 62 ± 51 ± 61 (–1 to 3)
 Postoperative hospital stay, d, median (IQR)7 (6–11)12 (8–25)7 (6–10)9 (8 to 10)
 Vasoactive medication duration, d, median (IQR)1 (0.2–1)1 (0.3–3)0.5 (0.2–1)1 (0.6 to 1.2)
OR (95% CI)
 Vasoactive medication, frequency455 (86.0)45 (88.2)410 (85.8)1.35 (0.53 to 3.47)
 Re-admission to any ICU21 (4.0)5 (9.8)16 (3.3)2.74 (0.89 to 8.45)
 Mechanical ventilation ≥ 48 h25 (4.7)9 (17.6)16 (3.3)4.79 (1.82 to 12.65)
Hospital discharge dispositionp value
 Home (independent or with help)482 (91.1)33 (64.7)449 (93.9)< 0.001
 Subacute care28 (5.3)10 (19.6)18 (3.8)0.01
 Lodge or facility9 (1.7)3 (5.9)6 (1.3)0.1
Health-related quality of lifeMean difference (95% CI)
 Baseline EQ-VAS, mean ± SD58 ± 2146 ± 1960 ± 2015 (9 to 21)
 6-month EQ-VAS, mean ± SD72 ± 1762 ± 1573 ± 1612 (6 to 17)
 12-month EQ-VAS, mean ± SD75 ± 1760 ± 2276 ± 1515 (10 to 20)
  • Note: CFS = Clinical Frailty Scale, CI = confidence interval, CVICU = cardiovascular surgical intensive care unit, EQ-VAS = EuroQol health questionnaire with visual acuity scale, HR = hazard ratio, ICU = intensive care unit, IQR = interquartile range, OR = odds ratio, SD = standard deviation.

  • * Unless stated otherwise.

  • All reported comparisons were adjusted for age, sex and EuroSCORE II.